Technical Analysis for RGEN - Repligen Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Down | Weakness | 0.56% | |
| 20 DMA Resistance | Bearish | -0.76% | |
| Fell Below 200 DMA | Bearish | -0.76% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -0.76% | |
| MACD Bullish Signal Line Cross | Bullish | -0.76% | |
| Multiple of Ten Bearish | Other | -0.76% | |
| Inside Day | Range Contraction | -0.76% | |
| 20 DMA Resistance | Bearish | -2.74% | |
| Crossed Above 200 DMA | Bullish | -2.74% | |
| Pocket Pivot | Bullish Swing Setup | -2.74% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 12 hours ago |
| 60 Minute Opening Range Breakout | about 14 hours ago |
| Up 1% | about 14 hours ago |
| Fell Below 10 DMA | 1 day ago |
| 10 DMA Support | 1 day ago |
Free Daily (Stock) Chart Reading
- Earnings date: 04/30/2024
Repligen Corporation Description
Repligen Corporation, a life sciences company, engages in the development, production, and commercialization of consumable products used in the process of manufacturing biological drugs. Its bioprocessing products are sold to various life sciences and biopharmaceutical companies worldwide. The company manufactures Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. It also supplies various growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, the company develops and markets its OPUS brand series of pre-packed plug-and-play' chromatography columns, and provides ELISA test kits to ensure final product quality. Further, Repligen has a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and a orphan drug candidate in Phase 1 development. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Natural Sciences Monoclonal Antibody 3 D Orphan Drug Consumable Products Chromatography Imaging Agent Bioprocessing Cell Culture Bioprocess Drug Manufacturing Growth Factor Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 211.13 |
| 52 Week Low | 110.46 |
| Average Volume | 481,487 |
| 200-Day Moving Average | 170.58 |
| 50-Day Moving Average | 184.66 |
| 20-Day Moving Average | 169.96 |
| 10-Day Moving Average | 163.46 |
| Average True Range | 6.33 |
| RSI (14) | 42.20 |
| ADX | 25.93 |
| +DI | 21.61 |
| -DI | 26.71 |
| Chandelier Exit (Long, 3 ATRs) | 168.26 |
| Chandelier Exit (Short, 3 ATRs) | 171.18 |
| Upper Bollinger Bands | 185.42 |
| Lower Bollinger Band | 154.49 |
| Percent B (%b) | 0.39 |
| BandWidth | 18.20 |
| MACD Line | -5.98 |
| MACD Signal Line | -6.58 |
| MACD Histogram | 0.5955 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 171.70 | ||||
| Resistance 3 (R3) | 171.75 | 170.10 | 170.84 | ||
| Resistance 2 (R2) | 170.10 | 168.80 | 170.08 | 170.56 | |
| Resistance 1 (R1) | 168.34 | 168.00 | 169.22 | 168.29 | 170.27 |
| Pivot Point | 166.69 | 166.69 | 167.13 | 166.67 | 166.69 |
| Support 1 (S1) | 164.93 | 165.39 | 165.81 | 164.88 | 162.89 |
| Support 2 (S2) | 163.28 | 164.59 | 163.26 | 162.60 | |
| Support 3 (S3) | 161.52 | 163.28 | 162.32 | ||
| Support 4 (S4) | 161.47 |
